A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

NCT05953740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MK-5720
DRUG: Placebo to MK-5720
DRUG: MK-8189
DRUG: Placebo to MK-8189

Sponsor

Merck Sharp & Dohme LLC